Literature DB >> 8628261

Sch proteins are localized on endoplasmic reticulum membranes and are redistributed after tyrosine kinase receptor activation.

L V Lotti1, L Lanfrancone, E Migliaccio, C Zompetta, G Pelicci, A E Salcini, B Falini, P G Pelicci, M R Torrisi.   

Abstract

The intracellular localization of Shc proteins was analyzed by immunofluorescence and immunoelectron microscopy in normal cells and cells expressing the epidermal growth factor receptor or the EGFR/erbB2 chimera. In unstimulated cells, the immunolabeling was localized in the central perinuclear area of the cell and mostly associated with the cytosolic side of rough endoplasmic reticulum membranes. Upon epidermal growth factor treatment and receptor tyrosine kinase activation, the immunolabeling became peripheral and was found to be associated with the cytosolic surface of the plasma membrane and endocytic structures, such as coated pits and endosomes, and with the peripheral cytosol. Receptor activation in cells expressing phosphorylation-defective mutants of Shc and erbB-2 kinase showed that receptor autophosphorylation, but not Shc phosphorylation, is required for redistribution of Shc proteins. The rough endoplasmic reticulum localization of Shc proteins in unstimulated cells and their massive recruitment to the plasma membrane, endocytic structures, and peripheral cytosol following receptor tyrosine kinase activation could account for multiple putative functions of the adaptor protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8628261      PMCID: PMC231182          DOI: 10.1128/MCB.16.5.1946

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling.

Authors:  E J Lowenstein; R J Daly; A G Batzer; W Li; B Margolis; R Lammers; A Ullrich; E Y Skolnik; D Bar-Sagi; J Schlessinger
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

Review 2.  Pulling springs to tune transduction: adaptation by hair cells.

Authors:  A J Hudspeth; P G Gillespie
Journal:  Neuron       Date:  1994-01       Impact factor: 17.173

3.  Light and electron microscopic immunocytochemical localization of PKC delta immunoreactivity in the rat central nervous system.

Authors:  I Merchenthaler; Z Liposits; J J Reid; W C Wetsel
Journal:  J Comp Neurol       Date:  1993-10-15       Impact factor: 3.215

4.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

Authors:  G Pelicci; L Lanfrancone; F Grignani; J McGlade; F Cavallo; G Forni; I Nicoletti; F Grignani; T Pawson; P G Pelicci
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

5.  Phosphorylation of the SHC proteins on tyrosine correlates with the transformation of fibroblasts and erythroblasts by the v-sea tyrosine kinase.

Authors:  A J Crowe; J McGlade; T Pawson; M J Hayman
Journal:  Oncogene       Date:  1994-02       Impact factor: 9.867

6.  Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases.

Authors:  J McGlade; A Cheng; G Pelicci; P G Pelicci; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

7.  C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains.

Authors:  S G Clark; M J Stern; H R Horvitz
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

8.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.

Authors:  P P Di Fiore; J H Pierce; T P Fleming; R Hazan; A Ullrich; C R King; J Schlessinger; S A Aaronson
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

9.  Immunocytochemical analysis of the transfer of vesicular stomatitis virus G glycoprotein from the intermediate compartment to the Golgi complex.

Authors:  L V Lotti; M R Torrisi; M C Pascale; S Bonatti
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

10.  Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.

Authors:  T Tauchi; H S Boswell; D Leibowitz; H E Broxmeyer
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  21 in total

1.  Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo.

Authors:  K S Ravichandran; M M Zhou; J C Pratt; J E Harlan; S F Walk; S W Fesik; S J Burakoff
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA.

Authors:  Matt K Lee; Cécile Pardoux; Marie C Hall; Pierre S Lee; David Warburton; Jing Qing; Susan M Smith; Rik Derynck
Journal:  EMBO J       Date:  2007-08-02       Impact factor: 11.598

3.  The Shc locus regulates insulin signaling and adiposity in mammals.

Authors:  Alexey A Tomilov; Jon J Ramsey; Kevork Hagopian; Marco Giorgio; Kyoungmi M Kim; Adam Lam; Enrica Migliaccio; Kent C Lloyd; Ina Berniakovich; Tomas A Prolla; Piergiuseppe Pelicci; Gino A Cortopassi
Journal:  Aging Cell       Date:  2010-11-15       Impact factor: 9.304

4.  Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.

Authors:  E Migliaccio; S Mele; A E Salcini; G Pelicci; K M Lai; G Superti-Furga; T Pawson; P P Di Fiore; L Lanfrancone; P G Pelicci
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

5.  The PTB domain of ShcA couples receptor activation to the cytoskeletal regulator IQGAP1.

Authors:  Matthew J Smith; W Rod Hardy; Guang-Yao Li; Marilyn Goudreault; Steven Hersch; Pavel Metalnikov; Andrei Starostine; Tony Pawson; Mitsuhiko Ikura
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

6.  Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β).

Authors:  Shu Lin; Lan Yu; Junhua Yang; Zhao Liu; Bijal Karia; Alexander J R Bishop; James Jackson; Guillermina Lozano; John A Copland; Xiaoxin Mu; Beicheng Sun; Lu-Zhe Sun
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

7.  Developmental regulation of p66Shc is altered by bronchopulmonary dysplasia in baboons and humans.

Authors:  Matt K Lee; Gloria S Pryhuber; Margaret A Schwarz; Susan M Smith; Zdena Pavlova; Mary E Sunday
Journal:  Am J Respir Crit Care Med       Date:  2005-03-18       Impact factor: 21.405

8.  Polyomavirus large T antigen induces alterations in cytoplasmic signalling pathways involving Shc activation.

Authors:  V Gottifredi; G Pelicci; E Munarriz; R Maione; P G Pelicci; P Amati
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.

Authors:  Gang Xi; Xinchun Shen; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-07-07

10.  Nck-dependent activation of extracellular signal-regulated kinase-1 and regulation of cell survival during endoplasmic reticulum stress.

Authors:  Duc Thang Nguyên; Sem Kebache; Ali Fazel; Hetty N Wong; Sarah Jenna; Anouk Emadali; Eun-Hye Lee; John J M Bergeron; Randal J Kaufman; Louise Larose; Eric Chevet
Journal:  Mol Biol Cell       Date:  2004-06-16       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.